Table 3.
Top 25 ADEs suspected to be caused by remdesivir reported in 439 individuals in WHO database (N = 439)
| Sl. No. | ADEs | Frequency (%) |
|---|---|---|
| 1 | Hepatic enzyme increased | 141 (32.11) |
| 2 | Renal Injury | 63 (14.4) |
| 3 | Blood creatinine increased | 49 (11.2) |
| 4 | Medication Error | 34 (7.7) |
| 5 | Product Use in Unapproved Condition | 29 (6.6) |
| 6 | Respiratory failure | 28 (6.4) |
| 7 | Tachy or Bradyarrythmia | 26 (5.9) |
| 8 | Hypotension | 24 (5.5) |
| 9 | Rash | 22 (5.0) |
| 10 | Therapy cessation | 22 (5.0) |
| 11 | Condition Aggravated/Disease Progression | 19 (4.3) |
| 12 | Sepsis and Septic Shock | 18 (4.1) |
| 13 | Cardiac and Cardiorespiratory Arrest | 17 (3.9) |
| 14 | Nausea/Vomiting | 15 (3.4) |
| 15 | Glomerular filtration rate decreased | 14 (3.2) |
| 16 | Renal impairment | 14 (3.2) |
| 17 | Abnormal Hemogram | 13 (3.0) |
| 18 | Renal failure | 13 (3.0) |
| 19 | Death | 12 (2.7) |
| 20 | Multiorgan Disorder/Organ Failure | 11 (2.5) |
| 21 | Pyrexia | 11 (2.5) |
| 22 | Hypoxia | 11 (2.5) |
| 23 | Dialysis | 11 (2.5) |
| 24 | Diarrhea | 10 (2.3) |
| 25 | Acidosis | 10 (2.3) |